Lv41
670 积分 2024-02-06 加入
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
4分钟前
待确认
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China
17分钟前
已关闭
Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody
3个月前
已完结
A new era of antibody discovery: an in-depth review of AI-driven approaches
3个月前
已完结
Four ways to power-up AI for drug discovery
7个月前
已完结
ARNLE model identifies prevalence potential of SARS-CoV-2 variants
10个月前
已完结
Rapid in silico directed evolution by a protein language model with EVOLVEpro
1年前
已完结
Cancer therapy with antibodies
1年前
已完结
Five protein-design questions that still challenge AI
1年前
已完结
AI-driven antibody design with generative diffusion models: current insights and future directions
1年前
已完结
皖公网安备34019202002308
